TY - JOUR
T1 - Correction to
T2 - Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review (British Journal of Cancer, (2024), 10.1038/s41416-024-02887-1)
AU - Jayathilaka, Bishma
AU - Mian, Farah
AU - Franchini, Fanny
AU - Au-Yeung, George
AU - IJzerman, Maarten
N1 - Publisher Copyright: © The Author(s) 2024.
PY - 2024/12/10
Y1 - 2024/12/10
N2 - Correction to: British Journal of Cancerhttps://doi.org/10.1038/s41416-024-02887-1, published online 03 November 2024 In this article values in the sentence “Mean event rate for ICI monotherapy was 29.7% (27.7–33.2%), 45.7% (29.6–61.7%) for ICI combination therapy, and 30.3% (27.3–35.0%) for both ICI monotherapy and combination therapy.” are given erroneously. They should read “Mean event rate for ICI monotherapy was 30.5% (28.1–32.9%), 45.7% (29.6–61.7%) for ICI combination therapy, and 30.0% (25.3–34.6%) for both ICI monotherapy and combination therapy.” The original article has been corrected.
AB - Correction to: British Journal of Cancerhttps://doi.org/10.1038/s41416-024-02887-1, published online 03 November 2024 In this article values in the sentence “Mean event rate for ICI monotherapy was 29.7% (27.7–33.2%), 45.7% (29.6–61.7%) for ICI combination therapy, and 30.3% (27.3–35.0%) for both ICI monotherapy and combination therapy.” are given erroneously. They should read “Mean event rate for ICI monotherapy was 30.5% (28.1–32.9%), 45.7% (29.6–61.7%) for ICI combination therapy, and 30.0% (25.3–34.6%) for both ICI monotherapy and combination therapy.” The original article has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85212219115&partnerID=8YFLogxK
U2 - 10.1038/s41416-024-02920-3
DO - 10.1038/s41416-024-02920-3
M3 - Comment/Letter to the editor
C2 - 39658607
AN - SCOPUS:85212219115
SN - 0007-0920
JO - British Journal of Cancer
JF - British Journal of Cancer
ER -
